Ignite Creation Date:
2024-05-06 @ 9:30 AM
Last Modification Date:
2024-10-26 @ 12:15 PM
Study NCT ID:
NCT02990208
Status:
COMPLETED
Last Update Posted:
2016-12-13
First Post:
2016-12-05
Brief Title:
Diaphragmatic Breathing During Virtual Reality Exposure Therapy for Aviophobia
Sponsor:
University of Regensburg
Organization:
University of Regensburg
Study Overview
Official Title:
Diaphragmatic Breathing During Virtual Reality Exposure Therapy for Aviophobia Functional Coping Strategy or Avoidance Behavior A Pilot Study
Status:
COMPLETED
Status Verified Date:
2016-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study investigated the effect of diaphragmatic breathing as an additional coping strategy during Virtual Reality Exposure Therapy in patients with aviophobia The authors assumed that diaphragmatic breathing DB would lead to less fear and physiological arousal during the VRET and to an enhanced treatment outcome
Detailed Description:
Patients with aviophobia received treatment in Virtual Reality with or without DB The authors assumed that adding DB to VRET would enhance treatment effects by reducing fear during exposure thus improving the processing of the feared situation The authors hypothesized that as a result self-efficacy would be increased in comparison to VRET alone
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None